Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Project details
American clinical-stage life sciences company seeks investments
| Project region | United States |
|---|---|
| Industry | Healthcare |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
Simon Laube
Assistant Manager, International Business Advisory
| Project highlights | USD 29.5 billion 2020 market value - 11.4% expected CAGR |
|---|---|
| Project description |
The American company develops rapid diagnostics for the detection of any upper respiratory tract viral infection including all COVID. The global point-of-care-testing (POCT) market size in 2020 is valued at USD 29.5 billion and is expected to grow at a compound annual growth rate (CAGR) of 11.4% till 2025. Now the company seeks investments. |
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact Us